Dr. Rautio’s Solutions to Dry Eyes

As an optometrist specializing in the treatment of dry eye diseases (DED), I have found that screening for and treating the associated Meibomian Gland Dysfunction (MGD) has led to significant improvement in patient comfort. Moreover, it provides long-term resolution of their condition.

Initial Studies

In 2011, the Tear Film & Ocular Surface Society published a defining study indicating that Meibomian Gland Dysfunction (MGD) is one of the major causes of dry eye disease (DED). The study involved more than 50 global experts over the course of two years. In detail, it explored the structure and function of the Meibomian glands in our eyelids. It discovered that decreased function, due to excessive numbers of Staphylococcal bacteria and inflammation, had been greatly underestimated as one of the primary causes of dry eye disease.

Most patients today have, unfortunately, learned to accept their “dry eyes” as normal. According to a recent Harris Survey, most dry eye sufferers try at least three different tear supplements before giving up with little relief. Even though we now have prescription eye drops available for dry eye treatment, we have found that they don’t treat the main underlying cause of the problem. That main cause is MGD.

About 10 years ago, we started paying particularly close attention to the eyelids of our dry eye and post-LASIK patients. We found a tremendous number with completely plugged Meibomian gland openings. We now know that these plugged oil glands lead to a marked decrease in the lipid (oily) layer of the tear film. As a result, this leads to increased tear evaporation and increased signs and symptoms of dry eye.

Current MGD Research

Our experience, over the past decade, supports the current research suggesting MGD-related dry eye is one of the most overlooked ocular conditions found today. Fortunately, 80-90% of our patients with dry eyes benefit from a simple treatment regimen of heat, massage, and an antibiotic eye drop. We can also use Restasis and/or Xiidra in conjunction with these lid treatments on patients with systemic illnesses such as rheumatoid arthritis or diabetes. This is especially helpful because of their decreased tear production.

Lastly, even though there is no magic bullet, following our simple MGD protocol allows our patients to enjoy healthy, happy eyes and eyelids. In turn, this leads to the elimination of dry eye and the discomfort experienced before treatment!

About the Author

Dr. Jeff Rautio practices with Dr. Daniel S. Haddad at The Laser Eye Institute in Troy, Michigan. A graduate of the Michigan College of Optometry, Dr. Rautio specializes in LASIK, LASEK, SMILE, and Cataract pre-and post-operative care. He also has a sub-specialty in the diagnosis and treatment of DED and MGD.